SPONSOR
Hansoh BioMedical R&D Company
Total Trials
3
Recruiting
3
Phases
Phase 2, Phase 1
Conditions studied: OsteosarcomaSarcomaIgA NephropathyFocal Segmental GlomerulosclerosisAdvanced Solid Tumor
Hansoh BioMedical R&D Company is a clinical research sponsor with 3 registered studies on ClinicalTrials.gov, of which 3 are actively recruiting participants. Research covers conditions including Osteosarcoma, Sarcoma, IgA Nephropathy, Focal Segmental Glomerulosclerosis.
The trial portfolio spans Phase 2, Phase 1 studies, reflecting a pipeline that may include early-stage safety evaluations, mid-stage efficacy assessments, and large-scale confirmatory trials. All studies listed here are sourced directly from ClinicalTrials.gov and updated daily.
Frequently Asked Questions — Hansoh BioMedical R&D Company
How many clinical trials has Hansoh BioMedical R&D Company sponsored?
ClinicalMetric currently tracks 3 clinical trials sponsored by Hansoh BioMedical R&D Company, of which 3 are actively recruiting participants. These trials cover conditions including Osteosarcoma, Sarcoma, IgA Nephropathy. Trial counts are updated daily from ClinicalTrials.gov and reflect currently registered studies.
What therapeutic areas does Hansoh BioMedical R&D Company research focus on?
Hansoh BioMedical R&D Company clinical trials span Osteosarcoma, Sarcoma, IgA Nephropathy, Focal Segmental Glomerulosclerosis, Advanced Solid Tumor. The research pipeline includes Phase 2, Phase 1 trials, reflecting work from early-stage safety evaluation through large-scale efficacy studies.
How do I participate in a Hansoh BioMedical R&D Company clinical trial?
To participate in a Hansoh BioMedical R&D Company trial, review the active studies listed on this page, check each trial's specific eligibility criteria on ClinicalTrials.gov, and contact the trial site directly—not the sponsor's headquarters. Trial sites are academic medical centers, hospitals, or specialized research clinics. Your physician can facilitate a referral. ClinicalMetric lists all Hansoh BioMedical R&D Company trials with current recruitment status updated daily.
Clinical Trials by Hansoh BioMedical R&D Company
NCT05830123 Phase 2
Recruiting
ARTEMIS-002: HS-20093 in Patients With Relapsed or Refractory Osteosarcoma and Other Sarcomas
Osteosarcoma
NCT05942625 Phase 1
Recruiting
A First in Human Study to Evaluate Safety, Tolerability, Pharmacology of HS-10390 in Healthy Subjects
IgA Nephropathy
NCT06332170 Phase 1
Recruiting
ARTEMIS-101: A Study of HS-20093 Combinations in Patients With Advanced Solid Tumors
Advanced Solid Tumor
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: September 2026 · Data Methodology